G. MARJERRISON, M.D." AND R. P. KEOGH, R.E.T! The occipital EEG, integrated by a modulus voltage integrator to yield measurements of i) mean amplitude over time, ii) the coefficient of variation of integrated amplitude from moment to moment has been found less variable in signal content in chronic schizophrenics in several replicated studies (1, 4) . Those acute schizophrenics who hallucinated during the recording also had relatively invariable EEG's as compared to other acute schizophrenics or non-psychotic control subjects, although acute schizophrenics in general did not differ from the normals (4) . Mean integrated amplitude scores did not differ significantly between any of the groups, did not discriminate those patients hallucinating and showed no sex difference in our studies.
In hospitalized chronic schizophrenic patients the measure has been shown to be sensitive to clinical symptomatic change induced by antipsychotic agents of a wide variety (6), although correlations at one point in time did not relate the integrator scores to clinical symptomatic status across a patient sample. In our acute schizophrenic samples the five unmedicated patients had a higher mean coefficient of variation than the 55 receiving drugs (4): this posed the question of comparability of the acute schizophrenics, mostly medicated, with the unmedicated non-psychotic volunteers. ' 
Method
To study the question of the effects of antipsychotic drugs on EEG variability in acute schizophrenia and also to investigate the contribution of differences in perceptual function to EEG variability, 34 acute, newly admitted schizophrenics were selected. Each of these had received no tranquillizing medication for at least one month prior to admission and no electroconvulsive treatment for at least two months. All had clinically normal EEGs and were within the age range of 18-45 years.
Each patient had his EEG integrated before treatment and then was placed on a standard clinical dosage of chlorpromazine], haloperidolfj, or chlorprothixenettt for one week; in the case of the last two compounds the week on the drug was preceded or followed by a week of placebo (with repeat integration of the EEG at the end of the placebo week) in a randomized double-blind cross-over design. All the subjects were. tested with the Rod and Frame Test (7) . The patients studied in the haloperidol-chlorprothixene design also received symptom ratings on the 75-item Inpatient Multidimensional Psychiatric Scale (IMPS) of Lorr et at (3) before treatment and at the end of each of the seven-day drug and placebo treatment periods.
Results
The IMPS ratings conducted on the 20 patients receiving either chlorprothixene or haloperidol demonstrated clinical change over the week of drug treatment. Within each drug group Friedman tests showed significant differences between the treatment conditions: Morbidity Factor 2 (distortion of thinking and perception) was lower for the chlorprothixene patients while on drug (p < .03), and Morbidity Factor 3 (schizophrenic disorganization) for the haloperidol patients during the drug week (p < .03). Changes on the specific symptom factors of the IMPS did not discriminate the two drug groups with the small 'N' studied, but further patients will be selected and investigated. Drug treatment produced changes in the variability of the integrated EEGs, both in the direction of increases and decreases, as compared to the pre-treatment observations; these changes did not discriminate between the drug groups. However, significant relationships were observed between them and the druginduced changes in the IMPS symptom factor ratings for the 20 patients on haloperidol or chlorprothixene. PCP (Perceptual distortion) changes over the drug week correlated-.41 (rank order correlation: p < .05) with changes in the coefficient of variation scores of the EEG content; MTR (Motor Disturbance) difference scores also correlated -.50 (p < .05) with the changes in the EEG variability measure. In other words, drug induced increases in variability by either drug were significantly related to decreases in the amount of hallucinatory symptomatology and of the posturing, grimacing, and stereotyped motor signs of acute schizophrenia.
Further data analysis demonstrated a relationship between the measure used of perceptual field dependency" and the increases or decreases of variability under the various drug conditions. Chlorpromazine and chlorprothixene (chemically a phenothiazine analogue) produced an increase in EEG variability under drug as compared to pre-treatment conditions in those subjects more field independent (RFT scores less than 60; Table I , chi square significant at p < .05) and a decrease in those more field dependent. Haloperidol tended to distribute in the opposite way against the field dependency measure (Fischer Exact Probability < .08, see Table I ).
Discussions
In terms of group averages, acute schizophrenics do not differ from normal controls either in mean integrated amplitude or the variability of their occipital EEG signal content. The previously reported finding of lower coefficients of variation of the integrated EEG in those schizophrenics actually hallucinating during the recording suggested that investigation of EEG variability may contribute to an understanding of the disturbed perceptual processes involved in the symptomatology of some schizophrenics. In the present study the actual correlation between decreases in hallucinatory symptomatology (the PCP factor of the IMPS) and increases in EEG variability over a week of controlled *'*The Rod and Frame Test score is calculated as the sum of angular deviations from true vertical, over 8 runs, resulting from the biasing Influence of a tilted frame surrounding a bar which can be adjusted by the subject; the test scores distributed bimodally in our population of acute schizophrenics. drug treatment, plus the de~onstrati?n that field independent schizophrenics tend to increase in variability with phenothiazine drug treatment (and those field dependent tend to decrease), suggest even more strongly that the measure of EEG variability relates to the functional disturbance of perception, or 'sensory input processing' tha~has be~n described as a feature of schizophrenic psychopathology.
EEG invariability in schizophrenia may relate to other types of deficiency of physiological reactivity that have b~en reported (5), maybe even the specific lack of the 'alpha blocking' response to external stimuli which is seen in schizophrenics. Jasper (2) h~s su~~-g~st.ed that the reticular systems fail to inhibit selectively sensory inpu~in certai~psychotic conditions, producing a contmuou.s an.d sustained general arousal t? all stIm~h: effective cognitive processmg, selective attention and structuring of the perceptual environment may depend upon selective inhibitory controls in reticularcortical systems that function abnormally during certain schizophrenic states. Such control systems may be reflected also in the individual's style of perceptual analysis of sensory fields, as measured by the Rod and Frame Test.
Resume
Chez des schizophrenes a l'etat aigu mais ne recevant pas de medicaments, on a realise l'integration de I'E.E.G. avant et apres une semaine de traitement au moyen de la chlorpromazine (N-14), du chlorprothixene (10) ou de l'haloperidol (10). Les accroissements produits par les medicaments, de la variabilite des resultats de I'E.E.G. occipital ont concorde avec des diminutions des cotes de symptomatologie hallucinatoire dans Ie cas de ces deux derniers medicaments. Les changements survenus dans la variabilite de I'E.E.G. ne se rattachaient pas au genre de medicament ni al'etat anterieur au traiternent par rapport a I'administration de medicaments, mais, d'une maniere significative, ala dependance du champ mesure au moyen du test par les bdtonnets et Ies cadres, et l'haloperidol produisait un renversement de ce rapport par comparaison avec les deux autres medicaments. L'auteur traite de l'invariabilite de I'E.E.G. en fonction de ses rapports possibles avec les troubles d'absorption des impressions perceptuelles et de I'attention selective, dans Ia schizophrenic.
